Árpád Bátai

579 total citations
32 papers, 386 citations indexed

About

Árpád Bátai is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Árpád Bátai has authored 32 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 10 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Árpád Bátai's work include Chronic Myeloid Leukemia Treatments (11 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (6 papers). Árpád Bátai is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (6 papers). Árpád Bátai collaborates with scholars based in Hungary, United States and Germany. Árpád Bátai's co-authors include Péter Reményi, Tamás Masszi, Hajnalka Andrikovics, András Bors, Attila Tordai, Judit Csomor, Magdalena Koszarska, János Sinkó, S. Fekete and László Gopcsa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Árpád Bátai

28 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Árpád Bátai Hungary 13 253 152 138 71 61 32 386
Amine Belhabri France 14 272 1.1× 112 0.7× 147 1.1× 33 0.5× 95 1.6× 40 458
Nimitha R. Mathew Sweden 6 240 0.9× 114 0.8× 84 0.6× 232 3.3× 80 1.3× 7 436
László Gopcsa Hungary 13 132 0.5× 53 0.3× 79 0.6× 100 1.4× 92 1.5× 44 339
Hirotoshi Sakaguchi Japan 13 442 1.7× 204 1.3× 312 2.3× 108 1.5× 65 1.1× 51 752
Laura Tabellini United States 10 308 1.2× 203 1.3× 107 0.8× 264 3.7× 93 1.5× 13 613
Shin‐ichi Fuchida Japan 11 169 0.7× 44 0.3× 87 0.6× 55 0.8× 107 1.8× 38 294
Evgeny Klyuchnikov Germany 15 615 2.4× 203 1.3× 183 1.3× 149 2.1× 176 2.9× 57 715
Margaret M. Showel United States 10 340 1.3× 67 0.4× 168 1.2× 112 1.6× 126 2.1× 29 476
Evelyne D’Incan France 10 311 1.2× 88 0.6× 119 0.9× 51 0.7× 98 1.6× 23 410
D.C. Setubal Brazil 9 302 1.2× 95 0.6× 100 0.7× 71 1.0× 82 1.3× 21 390

Countries citing papers authored by Árpád Bátai

Since Specialization
Citations

This map shows the geographic impact of Árpád Bátai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Árpád Bátai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Árpád Bátai more than expected).

Fields of papers citing papers by Árpád Bátai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Árpád Bátai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Árpád Bátai. The network helps show where Árpád Bátai may publish in the future.

Co-authorship network of co-authors of Árpád Bátai

This figure shows the co-authorship network connecting the top 25 collaborators of Árpád Bátai. A scholar is included among the top collaborators of Árpád Bátai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Árpád Bátai. Árpád Bátai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bátai, Árpád, Mónika Fekete, László Gopcsa, et al.. (2024). Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol. Pathology & Oncology Research. 30. 1611720–1611720. 5 indexed citations
2.
Varga, Gergely, Zsolt Nagy, Judit Demeter, et al.. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. Pathology & Oncology Research. 25(4). 1615–1620. 17 indexed citations
3.
Tordai, Attila, András Bors, Hajnalka Andrikovics, et al.. (2019). Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning. PLoS ONE. 14(6). e0218945–e0218945. 8 indexed citations
4.
Bors, András, László Gopcsa, Árpád Bátai, et al.. (2019). Investigation of TGFB1 −1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(1). 215–223. 1 indexed citations
5.
Jagasia, Madan, Christof Scheid, Gèrard Socié, et al.. (2019). Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Blood Advances. 3(14). 2218–2229. 40 indexed citations
6.
Andrikovics, Hajnalka, Péter Reményi, Árpád Bátai, et al.. (2017). Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies. Human Immunology. 79(1). 13–19.
7.
Reményi, Péter, Árpád Bátai, András Bors, et al.. (2016). Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 58(2). 391–398. 7 indexed citations
8.
Reményi, Péter, Gergely Varga, Gábor Mikala, et al.. (2016). Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years. Transplantation Proceedings. 48(1). 177–184. 16 indexed citations
9.
Andrikovics, Hajnalka, Péter Reményi, Árpád Bátai, et al.. (2015). The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy. Bone Marrow Transplantation. 50(10). 1321–1325. 18 indexed citations
10.
Andrikovics, Hajnalka, András Bors, Magdalena Koszarska, et al.. (2014). Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations. Haematologica. 99(7). 1184–1190. 63 indexed citations
11.
Reményi, Péter, László Gopcsa, Marienn Réti, et al.. (2014). Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF. Advances in Therapy. 31(4). 451–460. 20 indexed citations
12.
Koszarska, Magdalena, András Bors, Árpád Bátai, et al.. (2013). Medium-sizedFLT3internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort. Leukemia & lymphoma. 55(7). 1510–1517. 15 indexed citations
13.
Andrikovics, Hajnalka, Árpád Bátai, András Bors, et al.. (2011). The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia. Haematologica. 96(11). 1613–1618. 14 indexed citations
14.
15.
Marschalkó, Márta, Péter Holló, Judit Hársing, et al.. (2010). Secondary ALK Negative Anaplastic Large Cell Lymphoma in a Patient With Lymphomatoid Papulosis of 40 Years Duration. American Journal of Dermatopathology. 32(7). 708–712. 3 indexed citations
16.
Sinkó, János, et al.. (2007). Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy‐driven survey. Transplant Infectious Disease. 10(2). 106–109. 38 indexed citations
17.
Bátai, Árpád, E Kelemen, Péter Reményi, et al.. (2000). Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state. Human Immunology. 61(2). 101–110. 13 indexed citations
18.
Kelemen, E, et al.. (1999). Responses to Single-Dose Thrombopoietin Decrease with Higher Platelet Counts in Mice. Acta Haematologica. 101(1). 41–45. 1 indexed citations
19.
Pócsik, Éva, Béla Z. Schmidt, Péter Reményi, et al.. (1995). Immunophenotypic and Functional Characteristics of Haemopoietic Cells from Human Cord Blood. Scandinavian Journal of Immunology. 42(4). 493–500. 12 indexed citations
20.
Bátai, Árpád, et al.. (1994). Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exon.. PubMed. 8(10). 1791–1791. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amine Belhabri Breakdown of academic impact, for papers by Nimitha R. Mathew Breakdown of academic impact, for papers by László Gopcsa Breakdown of academic impact, for papers by Hirotoshi Sakaguchi Breakdown of academic impact, for papers by Laura Tabellini Breakdown of academic impact, for papers by Shin‐ichi Fuchida Breakdown of academic impact, for papers by Evgeny Klyuchnikov Breakdown of academic impact, for papers by Margaret M. Showel Breakdown of academic impact, for papers by Evelyne D’Incan Breakdown of academic impact, for papers by D.C. Setubal
Rankless by CCL
2026